Physician profile
Shannon Garitty
NPI 1629414065
$92,417.23
in general payments reported to CMS, 2019-2025
26 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,151 · 2021: $5,430 · 2022: $5,728 · 2023: $3,690 · 2024: $31K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $12K · Travel and Lodging: $8,963 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,075 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,587.50 |
| Food and Beverage | $11,708.44 |
| Travel and Lodging | $8,962.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,075.00 |
| Education | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgentec | $38,311.49 | 2024-2025 | Tilink, Ion |
| Abbott Laboratories | $32,583.42 | 2019-2025 | Proclaim, Octrode, Eterna |
| Medtronic USA, INC. | $10,055.36 | 2019 | |
| Nevro Corp. | $2,486.44 | 2019-2020 | |
| Boston Scientific Corporation | $1,705.35 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Foundation Fusion Solutions, LLC | $1,506.82 | 2024-2025 | |
| Relievant Medsystems, INC. | $1,088.44 | 2022-2023 | Intracept |
| Stryker Corporation | $1,037.85 | 2024-2025 | Mild Device Kit |
| Spinal Simplicity, LLC | $792.39 | 2023-2025 | Ha Minuteman G3-R |
| Curonix LLC | $754.48 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $563.62 | 2021-2024 | Mild Device Kit |
| Nalu Medical, INC. | $353.38 | 2022-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $318.35 | 2024-2025 | Inceptiv, Intellis Adaptivestim, Synchromedii |
| Abbvie INC. | $206.79 | 2021-2025 | |
| Stimwave Technologies Incorporated | $162.54 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $87.69 | 2019 | |
| Painteq LLC | $83.87 | 2022 | |
| Mml US, INC. | $82.01 | 2023-2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $42.88 | 2024-2025 | Belbuca |
| Arbor Pharmaceuticals, INC. | $42.68 | 2019-2020 | |
| Spr Therapeutics, INC | $39.24 | 2022 | |
| Bioventus LLC | $29.19 | 2024 | Supartz Fx Sodium Hyaluronate |
| Biodelivery Sciences International, INC. | $26.13 | 2020-2021 | |
| Avanos Medical | $25.21 | 2024 | Standard Rf Disposables |
| Valinor Pharma, LLC | $17.54 | 2025 | Movantik |
| Allergan, INC. | $14.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Garitty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.